Dr. Elliott Bennett-Guerrero led a clinical trial at Stony Brook Medicine to test if administering blood plasma from recovered COVID-19 patients to those currently hospitalized could help treat the virus. The study found the treatment increased antibody levels but did not improve survival or other health outcomes. The results were published in Critical Care Medicine, the journal of the Society of Critical Care Medicine, an international organization focused on critical care.